Positron emission tomography probe demonstrates a striking concentration of ribose salvage in the liver

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 28, 2014, Pages

  Clark, Peter M ^a   Flores, Graciela ^a,b   Evdokimov, Nikolai M ^a,b   McCracken, Melissa N ^b   Chai, Timothy ^a   Nair Gill, Evan ^b   O'Mahony, Fiona ^a   Beaven, Simon W ^a   Faull, Kym F ^a,c   Phelps, Michael E ^a,b   Jung, Michael E ^a   Witte, Owen N ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Molecular imaging; Slc2a2; Sugar metabolism

Indexed keywords

2 DEOXY 2 FLUOROARABINOSE F 18; GLUCOSE; GLUCOSE TRANSPORTER 2; MESSENGER RNA; RADIOPHARMACEUTICAL AGENT; RIBOSE; TRANSKETOLASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD; CONTROLLED STUDY; GLUCOSE METABOLISM; HEART; IN VIVO STUDY; INTESTINE; KIDNEY; LIPID METABOLISM; LIVER; METABOLIC SYNDROME X; MOUSE; MUSCLE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; THYMUS;

MOLECULAR IMAGING; SLC2A2; SUGAR METABOLISM;

ANIMALS; ARABINOSE; CELL LINE; DISEASE MODELS, ANIMAL; FLUORINE RADIOISOTOPES; GLUCOSE; GLUCOSE TRANSPORTER TYPE 2; HUMANS; LIPID METABOLISM; LIVER; METABOLIC SYNDROME X; MICE; ORGAN SPECIFICITY; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RIBOSE;

EID: 84904303858     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1410326111     Document Type: Article

References (49)

1. Berg JM, Tymoczko JL, Stryer L (2002) Biochemistry (Freeman, New York).
2. Katz J, Abraham S, Hill R, Chaikoff IL (1955) The occurrence and mechanism of the hexose monophosphate shunt in rat liver slices. J Biol Chem 214(2):853-868.
3. Gross M, Zöllner N (1991) Serum levels of glucose, insulin, and C-peptide during long-term D-ribose administration in man. Klin Wochenschr 69(1):31-36.
4. Sanchez-Mata MC, Penuela-Teruel MJ, Camara-Hurtado M, Diez-Marques C, Torija-Isasa ME (1998) Determination of mono-, di-, and oligosaccharides in legumes by high-performance liquid chromatography using an amino-bonded silica column. J Agric Food Chem 46(9):3648-3652. (Pubitemid 128488178)
5. Naito Y (1944) Biochemical studies on d-Ribose, with special reference to the mechanism of absorption of sugars from intestinal tract. J Biochem 36(1):131-161.
6. Park J, van Koeverden P, Singh B, Gupta RS (2007) Identification and characterization of human ribokinase and comparison of its properties with E. coli ribokinase and human adenosine kinase. FEBS Lett 581(17):3211-3216. (Pubitemid 46977365)
7. Williams JF, Clark MG, Blackmore PF (1978) The fate of 14C in glucose 6-phosphate synthesized from [1-14C]Ribose 5-phosphate by enzymes of rat liver. Biochem J 176(1):241-256. (Pubitemid 9060532)
8. Doar JW, Wynn V, Cramp DG (1968) Blood pyruvate and plasma glucose levels during oral and intravenous glucose tolerance tests in obese and non-obese women. Metabolism 17(8):690-701.
9. Jellum E, Björnstad P (1964) Quantitative gas-liquid chromatographic determination of free glycerol in blood serum. J Lipid Res 5(3):314-317.
10. Mahoney JR, Jr, Sako EY, Seymour KM, Marquardt CA, Foker JE (1989) A comparison of different carbohydrates as substrates for the isolated working heart. J Surg Res 47(6):530-534. (Pubitemid 20012055)
11. Chang RS (1960) Genetic study of human cells in vitro. Carbohydrate variants from cultures of HeLa and conjunctival cells. J Exp Med 111(2):235-254.
12. Reitzer LJ, Wice BM, Kennell D (1980) The pentose cycle. Control and essential function in HeLa cell nucleic acid synthesis. J Biol Chem 255(12):5616-5626.
13. Phelps ME (2000) Positron emission tomography provides molecular imaging of biological processes. Proc Natl Acad Sci USA 97(16):9226-9233.
14. Tillisch J, et al. (1986) Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 314(14):884-888. (Pubitemid 16126116)
15. Chugani HT, Phelps ME, Mazziotta JC (1987) Positron emission tomography study of human brain functional development. Ann Neurol 22(4):487-497. (Pubitemid 17164772)
16. Gonçalves RP, Bennett GC, Leblond CP (1969) Fate of 3H-ribose in the rat as detected by radioautography. Anat Rec 165(4):543-557.
17. Malarkey DE, Johnson K, Ryan L, Boorman G, Maronpot RR (2005) New insights into functional aspects of liver morphology. Toxicol Pathol 33(1):27-34. (Pubitemid 40216801)
18. Alpini G, Phillips JO, Vroman B, LaRusso NF (1994) Recent advances in the isolation of liver cells. Hepatology 20(2):494-514. (Pubitemid 24233378)
19. Ciaraldi TP, Horuk R, Matthaei S (1986) Biochemical and functional characterization of the rat liver glucose-transport system. Comparisons with the adipocyte glucosetransport system. Biochem J 240(1):115-123. (Pubitemid 17191720)
20. Lager I, Fehr M, Frommer WB, Lalonde S (2003) Development of a fluorescent nanosensor for ribose. FEBS Lett 553(1-2):85-89. (Pubitemid 37206329)
21. Zhao FQ, Keating AF (2007) Functional properties and genomics of glucose transporters. Curr Genomics 8(2):113-128.
22. Thorens B, Sarkar HK, Kaback HR, Lodish HF (1988) Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and beta-pancreatic islet cells. Cell 55(2):281-290.
23. Hayashi K, Kojima R, Ito M (2006) Strain differences in the diabetogenic activity of streptozotocin in mice. Biol Pharm Bull 29(6):1110-1119. (Pubitemid 43845468)
24. Iwatsuka H, Shino A, Suzuoki Z (1970) General survey of diabetic features of yellow KK mice. Endocrinol Jpn 17(1):23-35.
25. Gallou-Kabani C, et al. (2007) C57BL/6J and A/J mice fed a high-fat diet delineate components of metabolic syndrome. Obesity (Silver Spring) 15(8):1996-2005. (Pubitemid 47402231)
26. Shimomura I, Bashmakov Y, Horton JD (1999) Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem 274(42):30028-30032.
27. Biddinger SB, et al. (2005) Effects of diet and genetic background on sterol regulatory element-binding protein-1c, stearoyl-CoA desaturase 1, and the development of the metabolic syndrome. Diabetes 54(5):1314-1323. (Pubitemid 40586659)
28. Anstee QM, Goldin RD (2006) Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol 87(1):1-16.
29. Elliott J, Hems DA, Beloff-Chain A (1971) Carbohydrate metabolism of the isolated perfused liver of normal and genetically obese - Hyperglycaemic (ob-ob) mice. Biochem J 125(3):773-780.
30. Elliott J, Dade E, Salmon DM, Hems DA (1974) Hepatic metabolism in normal and genetically obese mice. Biochim Biophys Acta 343(2):307-323.
31. Assimacopoulos-Jeannet F, Singh A, Le Marchand Y, Loten EG, Jeanrenaud B (1974) Abnormalities in lipogenesis and triglyceride secretion by perfused livers of obesehyperglycaemic (ob-ob) mice: Relationship with hyperinsulinaemia. Diabetologia 10(2):155-162.
32. Grundy SM (2008) Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 28(4):629-636.
33. Moller DE, Kaufman KD (2005) Metabolic syndrome: A clinical and molecular perspective. Annu Rev Med 56:45-62. (Pubitemid 40299773)
34. Watanabe S, Yaginuma R, Ikejima K, Miyazaki A (2008) Liver diseases and metabolic syndrome. J Gastroenterol 43(7):509-518.
35. Grundy SM, et al.; American Heart Association; National Heart, Lung, and Blood Institute (2005) Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112(17):2735-2752. (Pubitemid 41532612)
36. Festi D, et al. (2013) Review article: The diagnosis of non-alcoholic fatty liver disease - Availability and accuracy of non-invasive methods. Aliment Pharmacol Ther 37(4): 392-400.
37. Malnick SD, Beergabel M, Knobler H (2003) Non-alcoholic fatty liver: A common manifestation of a metabolic disorder. QJM 96(10):699-709. (Pubitemid 37259360)
38. Jargiello P (1982) Altered expression of ribokinase activity in Novikoff hepatoma variants. Biochim Biophys Acta 698(1):78-85.
39. Bailey AJ, Sims TJ, Avery NC, Halligan EP (1995) Non-enzymic glycation of fibrous collagen: Reaction products of glucose and ribose. Biochem J 305(Pt 2):385-390.
40. Valencia JV, et al. (2004) Advanced glycation end product ligands for the receptor for advanced glycation end products: Biochemical characterization and formation kinetics. Anal Biochem 324(1):68-78. (Pubitemid 37491125)
41. Brownlee M, Cerami A, Vlassara H (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318(20): 1315-1321.
42. Odetti P, Fogarty J, Sell DR, Monnier VM (1992) Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes 41(2):153-159.
43. Kerkeni M, et al. (2013) Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients. Diab Vasc Dis Res 10(3):239-245.
44. Guillam MT, et al. (1997) Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2. Nat Genet 17(3):327-330.
45. Burcelin R, del Carmen Muñoz M, Guillam MT, Thorens B (2000) Liver hyperplasia and paradoxical regulation of glycogen metabolism and glucose-sensitive gene expression in GLUT2-null hepatocytes. Further evidence for the existence of a membrane-based glucose release pathway. J Biol Chem 275(15):10930-10936. (Pubitemid 30212729)
46. Seyer P, et al. (2013) Hepatic glucose sensing is required to preserve β cell glucose competence. J Clin Invest 123(4):1662-1676.
47. Santer R, et al. (1997) Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome. Nat Genet 17(3):324-326. (Pubitemid 27475997)
48. Manz F, et al. (1987) Fanconi-Bickel syndrome. Pediatr Nephrol 1(3):509-518. (Pubitemid 18016653)
49. Wilson WA, Wang Z, Roach PJ (2002) Systematic identification of the genes affecting glycogen storage in the yeast Saccharomyces cerevisiae : Implication of the vacuole as a determinant of glycogen level. Mol Cell Proteomics 1(3): 232-242.